Limited Mobile Version
Follow this company and never miss a research update
IRLAB A

IRLAB Therapeutics

Market Cap 1,039.5M
Today
Day High
149.75
147.75
Day Low
147.75
Day Open
150.00
Prev Close
148.50
VWAP
148.9
Volume
1K
Turnover
0.177M
Top Broker
DDB
VWAP
149.3
Avg Volume
3K
Avg Turnover
0.500M
Top Brokers
AVA/DDB
VWAP
145.3
Avg Volume
4K
Avg Turnover
0.578M
Top Brokers
AVA/DDB
VWAP
149.3
Avg Volume
4K
Avg Turnover
0.544M
Top Brokers
AVA/DDB
52 week summary
Price Range
43.6
Last
174.0
Beta
N/A
Market Cap
1,039.5M
Total Return
151.7%
Trailing P/E
N/A
Div Yield
N/A%
Shares Outstanding
7.0M
Next Earnings Date
15 Nov
Stock Exchange
First North Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.


Relative Price Strength
Change 3 Months 5.2%
Change 12 Months 122.4%
Volume Trend
Average Volume 10 vs 60 Days -39.7%
Price VS
52 Week High -15.1%
50 Day Moving Average -2.5%
200 Day moving Average 28.1%

Add article markers

Compare IRLAB Therapeutics to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Nicholas Waters, CEO
  • Executive board
  • Anders Vedin, Chairman of the board
Source: Millistream
Major Owners Equity Votes
Sivert Larsson Scholarship Foundation 10.0%
10.0%
FV Group AB 9.0%
9.0%
Avanza Pension 8.0%
8.0%
Philip Diklev 3.0%
3.0%
Danica Pension 3.0%
3.0%
Source: Millistream
Timeframe Transactions Net Shares
Last 12 weeks
1 Purchases
+ 176
5 Sales
- 3,173
Last 24 weeks
1 Purchases
+ 176
5 Sales
- 3,173
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Catalyst Potential is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Sign up Login
Source: Millistream FI
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Sign up Login
Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.


Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.


Community Posts

Be the first to write something about this company in the community.

Create new post